Core Scientific closed at $12.76 on Nov 4, down 10.39%, within 2.0% of its 52-week closing low. Volume of 24.3M shares was 1.56× its 20-day average (above normal).
Split-adjusted performance: -23.5% over one month, -48.2% over six months, -44.3% over one year.
In the quarter ended Jun 30, 2026, revenue was $164.20M, up 108.8% from a year earlier, with a net margin of -658.4%.
Short interest was 76.6M shares at the Oct 15 settlement, up 16.1% from the prior report (24.9% of float, 5.2 days to cover).